CORRECTION article

Front. Pharmacol., 25 August 2021

Sec. Translational Pharmacology

Volume 12 - 2021 | https://doi.org/10.3389/fphar.2021.741485

Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes

  • 1. Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States

  • 2. Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, United States

  • 3. Department of Physiology, Medical College of Wisconsin, Milwaukee, WI, United States

  • 4. Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI, United States

  • 5. Department of Veterans Affairs, Research Service, Zablocki VAMC, Milwaukee, WI, United States

  • 6. Institute for Health and Equity, Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, United States

  • 7. Bolder BioTechnology Inc., Boulder, CO, United States

  • 8. Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States

Article metrics

View details

7

Citations

1,1k

Views

551

Downloads

In the original article, there was a mistake in Figures 2, 4, 9 as published. “The y axis was incorrectly labeled as 0-100, whereas it should be labeled 100-0.” The corrected Figures 2, 4, 9 appear below.

FIGURE 2

FIGURE 4

FIGURE 9

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

polypharmacy, acute radiation syndrome, delayed effects of acute radiation exposure, mitigation, hematopoietic growth factor, lisinopril, supportive care, radiation pneumonitis

Citation

Gasperetti T, Miller T, Gao F, Narayanan J, Jacobs ER, Szabo A, Cox GN, Orschell CM, Fish BL and Medhora M (2021) Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes. Front. Pharmacol. 12:741485. doi: 10.3389/fphar.2021.741485

Received

14 July 2021

Accepted

09 August 2021

Published

25 August 2021

Volume

12 - 2021

Edited and reviewed by

Ann Farese, University of Maryland, Baltimore, United States

Updates

Copyright

*Correspondence: Tracy Gasperetti,

†These authors have contributed equally to this work and share first authorship

This article was submitted to Translational Pharmacology, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics